Pathophysiology of the intrahepatic biliary epithelium

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 3, 2000, Pages 244-253

  Strazzabosco, Mario ^a   Spirlì, Carlo ^a   Okolicsanyi, Lajos ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Apoptosis; Cholangiocytes; Cholestasis; Cystic fibrosis; Cytokines

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GASTROINTESTINAL HORMONE; IMMUNOGLOBULIN A; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPEPTIDE; NEUROTRANSMITTER; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ALKALINITY; AUTOIMMUNITY; BILE DUCT ATRESIA; BILE SECRETION; CELL PROLIFERATION; CHOLESTASIS; CYSTIC FIBROSIS; CYTOKINE RELEASE; HORMONAL REGULATION; INTRAHEPATIC BILE DUCT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0034076048     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02091.x     Document Type: Review

References (86)

1. Strazzabosco M. New insights into cholangiocyte physiology. J. Hepatol. 1997; 27: 945-52.
2. Tavoloni N. The intrahepatic biliary epithelium: An area of growing interest in hepatology. Semin. Liver Dis. 1987; 7: 280-92.
3. Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. Hepatology 1991; 14: 551-66.
4. Alpini G, Glaser S, Robertson W et al. Bile acid stimulates proliferative and secretory events in large but not small cholangiocytes. Am. J. Physiol. 1997; 273: G518-29.
5. Strazzabosco M. Biliary tract physiology. Curr. Opin. Gastroenterol. 1998; 14: 395-401.
6. Boyer JL. Bile duct epithelium: Frontiers in transport physiology. Am. J. Physiol. 1996; 270: G1-5.
7. Strazzabosco M, Mennone A, Boyer JL. Intracellular pHi regulation in bile ductular cells isolated from bile duct ligated rats. J. Clin. Invest. 1991; 87: 1503-12.
8. 3 transport in cultured human intrahepatic bile duct cells. Hepatology 1997; 25: 976-85.
9. +-2Cl cotransport participates in stimulated fluid secretion in isolated polarized bile duct units from rat liver. Hepatology 1996; 26: 279A (Abstract).
10. Cohn JA, Strong TV, Picciotto MR, Nairn AC, Collins FS, Fitz JG. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 1993; 105: 1857-64.
11. McGill JM, Gettys TW, Basavappa S, Fitz JG. GTP-binding proteins regulate high conductance anion channels in rat bile duct epithelial cells. J. Membr. Biol. 1993; 133: 253-61.
12. 3 exchangers in a rat cholangiocyte cell line. Am. J. Physiol. 1998; 275: G1236-45.
13. Lazaridis KN, Pham L, Vroman B, de Groen PC, LaRusso NF. Kinetic and molecular identification of sodium-dependent glucose transporter in normal rat cholangiocytes. Am. J. Physiol. 1997; 272: G1168-74.
14. Eisemann-Tappe I, Wizigmann S, Gebhardt R. Glutamate uptake in primary cultures of biliary epithelial cells from normal rat liver. Cell Biol. Toxicol. 1991; 7: 315-25.
15. Lazaridis KN, Pham L, Tiets P et al. Rat cholangiocytes adsorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J. Clin. Invest. 1997; 100: 2714-21.
16. Marinelli RA, Pham L, Agre P, LaRusso NF. Secretin promotes osmotic water transport in rat cholangiocytes by increasing aquaporin-1 water channels in plasma membranes. Evidence for a secretin-induced vesicular translocation of aquaporin-1. J. Biol. Chem. 1997; 272: 12 984-8.
17. 3 exchange in cholangiocytes. Am. J. Physiol. 1997; 273: G303-13.
18. Lenzen R, Alpini G, Tavoloni N. Secretin stimulates bile ductular secretory activity through the cAMP system. Am. J. Physiol. 1992; 263: G527-32.
19. Cho WK, Mennone A, Boyer JL. VIP stimulates bile secretion in cholangiocytes by cAMP-PKA independent mechanisms. Hepatology 1997; 26: 397A (Abstract).
20. Cho WK, Mennone A, Rydberg SA, Boyer JL. Bombesin stimulates bicarbonate secretion from rat cholangiocytes: Implications for neural regulation of bile secretion. Gastroenterology 1997; 113: 311-21.
21. Glass GB. Gastrointestinal peptide hormones as modulators of bile secretion. Prog. Liver Dis. 1982; 7: 243-60.
22. Cai W, Gu J, Huang W et al. Peptide immunoreactive nerves and cells of the guinea pig gallbladder and biliary pathways. Gut 1983; 24: 1186-93.
23. Alvaro D. Biliary epithelium: A new chapter in cell biology. Ital. J. Gastroenterol. Hepatol. 1999; 31: 78-83.
24. Chari RS, Schutz SM, Haebig JE et al. Adenosine nucleotides in bile. Am. J. Physiol. 1996; 270: G246-52.
25. Schlosser SF, Burgstahler AD, Nathanson MH. Isolated rat hepatocytes can signal to other hepatocytes and bile duct cells by release of nucleotides. Proc. Natl Acad. Sci. USA 1996; 63: 9948-53.
26. Schlenker T, Roman JMJ, Sharara AC et al. Regulation of biliary secretion through apical purinergic receptors in cultured rat cholangiocytes. Am. J. Physiol. 1997; 273: G1108-17.
27. Zsembery A, Spirli C, Granato A et al. Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. Hepatology 1998; 28: 914-20.
28. +-dependent bile acid transporter in large but not small rat cholangiocytes. Gastroenterology 1997; 113: 1734-40.
29. Wolkoff AW, Suchy FJ, Moseley RH et al. Advances in hepatic transport: Molecular mechanisms, genetic disorders and treatment. A summmary of the 1998 AASLD single topic conference. Hepatology 1998; 28: 1713-19.
30. Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: Interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 1994; 20: 376-82.
31. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors β1 and β2 are differentially expressed in fibrotic liver disease. Am. J. Pathol. 1991; 139: 1221-9.
32. Caligiuri A, Glaser S, Rodgers RE et al. Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. Am. J. Physiol. 1998; 275: G835-46.
33. Marra F, De Franco R, Grappone C et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infiltration. Am. J. Pathol. 1998; 152: 423-30.
34. Morland CM, Fear J, McNab G et al. Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. Proc. AAP 1997; 109: 372-82.
35. Yasoshima M, Kono N, Sugawara H, Katayanagi K, Harada K, Nakanuma Y. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: In situ and culture study. Lab. Invest. 1998; 78: 89-100.
36. Vos TA, Gouw ASH, Klok PA et al. Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology 1997; 113: 1323-33.
37. Roberts SK, LaRusso NF. Pathobiology of biliary epithelia. Curr. Opin. Gastroenterol. 1994; 10: 526-33.
38. Woolf GM, Vierling JM. Disappearing intrahepatic bile ducts: The syndromes and their mechanisms. Semin. Liver Dis. 1993; 13: 261-75.
39. Sakamoto T, Liu Z, Murase N et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 1999; 29: 403-11.
40. Friedman SL. Cytokines and fibrogenesis. Semin. Liver Dis. 1999; 19: 129-40.
41. Ayres RCS, Neuberger JM, Shaw J, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: Effect of proinflammatory cytokines. Gut 1993; 34: 1245-9.
42. Terada T, Nakanuma Y. Detection of apoptosis and expression of apoptosis-related proteins during human intrahepatic bile duct development. Am. J. Pathol 1995; 146: 67-74.
43. Bhathal PS, Gall JA. Deletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimulus. Liver 1985; 5: 311-25.
44. Chen XM, Levine SA, Tietz P et al. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology 1998; 28: 907-13.
45. Chen XM, Gores GJ, Paya CV, LaRusso NF. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am. J. Physiol. 1999; 277: G599-608.
46. Mano Y, Ishii M, Okamoto H, Igarashi T, Kobayashi K, Toyota T. Effect of tumor necrosis factor alpha on intrahepatic bile duct epithelial cell of rat liver. Hepatology 1996; 23: 1602-7.
47. Patel T, LaRusso NF, Gores JG. IL-6 suppresses cholangiocyte apoptosis by down-regulation of Bax. Hepatology 1997; 26: 226A (Abstract).
48. Rodrigues CMP, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 1998; 101: 2790-9.
49. De Vree JML, Jacquemin E, Sturm E et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl Acad. Sci. USA 1998; 95: 282-7.
50. Smit JJ, Schinkel AH, Oude Elferink RP et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-62.
51. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 1997; 25: 1077-84.
52. Joplin R, Lindsay JG, Johnson GD, Strain A, Neuberger J. Membrane dihydrolipoamideacetyltransferase (E2) on human biliary cirrhosis. Lancet 1992; 339: 93-4.
53. Van de Water J, Turchany J, Leung PSC et al. Molecular mimicry in primary biliary cirrhosis. J. Clin. Invest. 1993; 91: 2653-64.
54. Malborg AC, Schultz DB, Luton F et al. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis. J. Autoimmun. 1998; 11: 573-80.
55. Desmet VJ, Roskams T,Van Eyken P. Ductular reaction in the liver. Pathol. Res. Pract. 1995; 191: 513-24.
56. Roskams T, van Der Oord JJ, DeVos R, Desmet V. Neuroendocrine features of reactive bile ductules in cholestatic liver diseases. Am. J. Pathol. 1990; 137: 1019-25.
57. Alpini G, Glaser SS, Ueno Y et al. Bile acid feeding induces cholangiocytes proliferation and secretion: Evidence for bile acid-regulated ductal secretion. Gastroenterology 1999; 116: 179-86.
58. Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21: 113-19.
59. Harada K, Van de Water J, Leung PSC et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of Th1 subset. Hepatology 1997; 25: 791-6.
60. Berg PA, Klein R, Rocken M. Cytokines in primary biliary cirrhosis. Semin. Liver Dis. 1997; 17: 115-23.
61. Adams DH. Biliary epithelial cells: Innocent victims or active participants in immune-mediated liver disease? J. Lab Clin. Med. 1996; 128: 528-30.
62. Lefkovitch JH. Bile ductular cholestasis: An ominous histopathologic sign related to sepsis and 'cholangitis lenta'. Human Pathol. 1981; 13: 19-24.
63. Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver 1998; 18: 2-13.
64. Herbst H, Frey A, Heinrichs O et al. Heterogeneity of liver cells expressing procollagen type I and IV in vivo. Histochem. Cell Biol. 1997; 107: 399-409.
65. Terada T, Nakanuma Y. Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and intrahepatic cholangiocarcinoma. Histopathology 1994; 25: 143-50.
66. Green RM, Whiting JF, Rosenbluth AB, Beier D, Gollan JL. Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphate activity. Am. J. Physiol. 1994; 267: G1094-100.
67. Alpini G, Lenzi R, Zhai WR, Slott PA, Lin MH, Tavoloni N. Bile secretory function of intrahepatic biliary epithelium in the rat. Am. J. Physiol. 1989; 257: G124-33.
68. Alpini G, Ulrich II CD, Phillips JO, Pham LD, Miller JL, LaRusso NF. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am. J. Physiol. 1994; 266: G922-8.
69. Slott PA, Liu MH, Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990; 99: 466-77.
70. Arias IM. New genetics of inheritable jaundice and cholestatic liver disease. Lancet 1998; 352: 82-3.
71. Colombo C, Battezzati PM, Strazzabosco M, Podda M. Liver and biliary problems in cystic fibrosis. Semin. Liver Dis. 1998; 18: 227-35.
72. Stutts MJ, Canessa CM, Olsen JC. CFTR as a cAMP-dependent regulator of sodium channels. Science 1995; 269: 847-50.
73. + channel (ROMK2) to the inhibitory sulfonylurea compound glybenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis trans-membrane regulator. Proc. Natl Acad. Sci. USA 1996; 93: 8083-8.
74. Egan M, Flotte T, Afion S. Defective regulation of outwardly rectifiying Cl channels by protein kinase A corrected by insertion of CFTR. Nature 1992; 358: 581-4.
75. Kopelman HR, Corey M, Gaskin KJ, Durie P, Forstner GG. Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid and secretory defect in the cystic fibrosis pancreas. Gastroenterology 1988; 98: 349-55.
76. Schwiebert EM, Egan E, Hwang TH. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 1995; 81: 1063-73.
77. Barasch J, Kiss B, Prince A, Saiman L, Gruenert D, Al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature 1991; 352: 70-3.
78. Bradbury NA, Bridges RJ. Role of membrane trafficking in plasma membrane solute transport. Am. J. Physiol. 1994; 267: C1-24.
79. 3 secretion across murine duodenum. Am. J. Physiol. 1998; 274: G718-26.
80. Bals R, Weiner DJ, Wilson JM. The innate immune system in cystic fibrosis lung disease. J. Clin. Invest. 1999; 103: 303-7.
81. 2+-activated Cl channels can substitute for CFTR in stimulation of anion-exchanger in human isolated CF cholangiocytes. J. Hepatol. 1999; 30: 141 (Abstract).
82. Prieto J, Qian C, Garcia N, Diez J, Medina JF. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology 1993; 105: 572-8.
83. Medina JF, Martinez A, Vasquez JJ, Prieto J. Decreased anion exchanger-2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology 1997; 25: 12-17.
84. Balfour Sartor R. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 1994; 106: 533-9.
85. Schuppan D, Hahn EG. Fibrogenesis in PBC. In: Lindor DK, Heathcote EJ, Poupon R. eds. Primary Biliary Cirrhosis: From Pathogenesis to Clinical Treatment. Dordrecht: Kluwer Academic Publishers, 1998.
86. - exchanger activity and expression. Hepatology 1999; 30: 417A (Abstract).